Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Cardiac Surgery
The Effect of Ultrasound-Guided Bilateral Single-Shot Serratus Posterior Superior Intercostal Plane Block on Recovery After Cardiac Surgery
1 other identifier
interventional
50
1 country
1
Brief Summary
This prospective, randomized, controlled study aims to evaluate the effects of ultrasound-guided bilateral single-shot serratus posterior superior intercostal plane (SPSIP) block on postoperative recovery and pain management in patients undergoing cardiac surgery. A total of 50 adult patients will be randomized into two groups: an SPSIP block group and a control group. The investigators will assess postoperative pain, opioid consumption, and quality of recovery during the postoperative period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2026
CompletedStudy Start
First participant enrolled
August 20, 2026
CompletedFirst Posted
Study publicly available on registry
August 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2027
August 25, 2026
August 1, 2026
4 months
August 10, 2026
August 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Quality of Recovery Assessed by QoR-15T
Postoperative quality of recovery will be assessed using the Turkish version of the Quality of Recovery-15 questionnaire (QoR-15T). The QoR-15T consists of 15 items assessing multiple dimensions of postoperative recovery. The total score ranges from 0 to 150, with higher scores indicating better quality of recovery.
Postoperative 24 hours
Secondary Outcomes (8)
Total Postoperative Tramadol Consumption
From the end of surgery to postoperative 48 hours
Postoperative Pain Intensity
Postoperative 2, 4, 6, 8, 10, 12, 24, 36, and 48 hours
Number of Participants With Postoperative Nausea and/or Vomiting (PONV)
Postoperative 2, 4, 6, 8, 10, 12, 24, 36, and 48 hours
Intensive Care Unit Length of Stay
From postoperative ICU admission until first ICU discharge, an average of 7 days
Ward Length of Stay
From first ICU discharge until hospital discharge, an average of 14 days
- +3 more secondary outcomes
Study Arms (2)
SPSIP Block Group
ACTIVE COMPARATORParticipants in this group will receive ultrasound-guided bilateral single-shot serratus posterior superior intercostal plane (SPSIP) block in addition to standard perioperative care.
Control Group
ACTIVE COMPARATORParticipants in this group will receive standard perioperative care without SPSIP block.
Interventions
After induction of general anesthesia, an ultrasound-guided bilateral serratus posterior superior intercostal plane (SPSIP) block will be performed at the level of the third rib. Under ultrasound guidance, the needle will be advanced to the fascial plane between the serratus posterior superior muscle and the intercostal muscles. After confirmation of appropriate needle-tip position, 20 mL of 0.25% bupivacaine will be administered on each side. The same procedure will then be performed on the contralateral side.
Participants in the control group will receive standard perioperative care without serratus posterior superior intercostal plane (SPSIP) block. The perioperative management and postoperative follow-up protocol will otherwise be the same as in the SPSIP block group.
Eligibility Criteria
You may qualify if:
- Patients aged 18-80 years
- Patients scheduled for elective cardiac surgery
- American Society of Anesthesiologists (ASA) physical status III--IV
- Patients who provide written informed consent to participate in the study
You may not qualify if:
- Patient refusal to participate in the study
- Known allergy to local anesthetics
- Infection at the site of block application
- Coagulopathy or contraindication to regional anesthesia
- Emergency surgery
- Patients unable to communicate adequately or complete the study assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Burak Çilingirlead
Study Sites (1)
Adıyaman Training and Research Hospital
Adıyaman, 02100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Postoperative outcome assessments will be performed by an investigator who is blinded to group allocation. The anesthesiologist performing the SPSIP block will not be involved in postoperative outcome assessment.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Resident Physician
Study Record Dates
First Submitted
August 10, 2026
First Posted
August 25, 2026
Study Start
August 20, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
February 1, 2027
Last Updated
August 25, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share